• BIO-key International shareholders approved issuance of up to 1,236,668 common shares upon warrant exercise at the October 30, 2026 annual meeting.
• The warrants were issued in the August 10, 2026 warrant inducement transaction.
• The meeting initially convened September 3, 2026; shareholders approved three other proposals at its October 2, 2026 reconvening.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-034242), on October 30, 2026, and is solely responsible for the information contained therein.